Dr. Paul Cannon is the Parkinson’s Disease Program Manager at 23andMe. Paul received his Master’s degree in Natural Sciences from Christ’s College in Cambridge and his PhD in Medical Sciences from the University of Calgary. Afterwards, he worked as a Research Scientist at Syntex. Next, Paul spent nearly 15 years in various roles at Roche Pharmaceuticals and Genentech. He worked as a Senior Consultant for Tynan Consulting for about four years before joining the team at 23andMe. In our interview, Paul tells us more about his life and science.
Dr. Cori Richards-Zawacki is an Associate Professor in the Department of Biological Sciences and Director of the Pymatuning Lab of Ecology at the University of Pittsburgh. Cori received her Bachelor’s degree in engineering and biology as well as her PhD in ecology and evolutionary biology both from the University of Michigan. She conducted postdoctoral research at the Smithsonian Institute and the University of California, Berkeley. Cori next served on the faculty at Tulane University prior to joining the faculty at the University of Pittsburgh in 2015. In our interview, Cori shares more about her life and science.
Dr. Jim Doherty is Chief Research Officer at Sage Therapeutics, a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-altering central nervous system disorders. Jim received his B.A. in biology from the University of Delaware and his Ph.D. in neuroscience from Georgetown University. Next, he conducted postdoctoral research at Emory University Medical School and subsequently served on the faculty at Emory for about two years. Prior to joining the team at Sage in 2014, Jim worked for about eleven years at AstraZeneca Pharmaceuticals. In our interview Jim shares more about his life and science.
Dr. Neil Solomons is Chief Medical Officer and Co-Founder of Aurinia Pharmaceuticals, a clinical stage biopharmaceutical company focused on developing and commercializing therapies in disease areas of high unmet medical need. Neil was awarded his Medical Degree from the University of London’s Guys Hospital Medical School. Afterwards, he worked as a physician in London and completed specialist training in anesthesia and intensive care. Neil held positions at Roche Pharmaceuticals, Aspreva Pharmaceuticals, and Vifor Pharma before co-founding Aurinia. In our interview Neil will tell us more about his life and science.
Dr. Anne Fung is the Global Development Lead for the Port Delivery System with Ranibizumab and Lucentis at Genentech. She is also a practicing retina specialist and researcher at Pacific Eye Associates and California Pacific Medical Center in San Francisco. Anne received her undergraduate degree from Wellesley College and her Medical Degree from Cornell University. She completed her residency in ophthalmology at Stanford University School of Medicine and then pursued a Medical Retina Fellowship at the Bascom Palmer Eye Institute and the University of Miami Miller School of Medicine. Anne worked in clinical practice for ten years before joining the team at Genentech in 2014. Anne is a Board Certified Ophthalmologist and is a Fellow of the American Academy of Ophthalmology. In our interview she shares more about her life and science.
Dr. Karl Heilbron is a Scientist I in Statistical Genetics at 23andMe. Karl received his Bachelor’s degree in Evolutionary Science from Western University where he was awarded the Western Gold medal for highest course average. He next attended The University of Oxford where he earned his Ph.D. degree in evolutionary genomics. Karl was awarded a Julie Payette Research Scholarship from The Natural Sciences and Engineering Research Council of Canada for his graduate work. Afterwards, Karl conducted postdoctoral research in computational biology at 23andMe before accepting his current position there. In our interview Karl will tell us more about his life and science.
Dr. Jennifer Wargo is an Associate Professor in the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center and a Stand Up To Cancer researcher. She received her A.S. degree in nursing and B.S. degree in biology from Gwynedd-Mercy College. Afterwards, Jennifer attended the Medical College of Pennsylvania where she earned her M.D. Jennifer completed her Clinical Internship and Residency in General Surgery at Massachusetts General Hospital. Next, Jennifer was a Research Fellow in Surgical Oncology at the University of California, Los Angeles. She then accepted a Clinical Residency in General Surgery at Massachusetts General Hospital. From 2006-2008, Jennifer was a Clinical Fellow in Surgical Oncology at the National Cancer Institute of the National Institutes of Health. She then served on the faculty at Massachusetts General Hospital and Harvard University. In 2012, Jennifer received her MMSc. degree in Medical Science from Harvard University. Jennifer joined the faculty at The University of Texas MD Anderson Cancer Center in 2013. She is Board Certified by the American Board of Surgery, and she has received numerous awards and honors throughout her career. These have included the R. Lee Clark Prize and Best Boss Award from the MD Anderson Cancer Center, the Rising STARS and The Regents’ Health Research Scholars Awards from the University of Texas System, the Outstanding Young Investigator and Outstanding Investigator Awards from the Society for Melanoma Research, as well as a Stand Up To Cancer Innovative Research Grant for her microbiome work. She has also received other awards for excellence in teaching, research, and patient care. In our interview, Jennifer shares more about her life and science.
Dr. Brian Goode is a Research Scientist at the Fralin Life Science Institute at Virginia Tech, formerly the Biocomplexity Institute. Brian received his B.S. and Ph.D. in mechanical engineering from Virginia Tech. He was awarded an Office of Naval Research assistantship to complete his doctoral work. Afterwards, Brian went on a working holiday visa to Australia where he was a Field Engineer for Infrastructure Management Group, a bartender in Port Douglas, Queensland, and started freelance web developing while traveling. He then became an English Teacher in Thailand, and a Logistics Engineer at JB Hunt Transport Services, Inc. before returning to Virginia Tech to accept a postdoctoral fellowship. In 2016, Brian transitioned into his current position as a Research Scientist at Virginia Tech, and in 2017, he was awarded an Innovation Award from the Fragile Families Challenge held at Princeton University. In our interview, Brian will tell us more about his life and research.
Dr. Edith Widder is Co-Founder, CEO, and Senior Scientist at the Ocean Research & Conservation Association (ORCA), a scientific based conservation nonprofit. Edie received a BS in Biology from Tufts University and worked as a Laboratory Technician at Harvard Medical School before enrolling in graduate school. She attended UC, Santa Barbara where she earned a MS in biochemistry and a PhD in Neurobiology. Prior to founding ORCA, Edie worked for 16 years as a senior scientist at Harbor Branch Oceanographic Institute. Edie has received numerous awards and honors throughout her career, including a MacArthur Fellowship, the 2018 Explorers Club Citation of Merit, Induction into the Women Diver’s Hall of Fame, and Certifications as a research pilot for single-person submersibles, including wasp, Deep Rover, and Deep Worker. Edie also has the honor of having her underwater images featured on seven of the ten recently released bioluminescence stamps from the U.S. Postal Service. In our interview, Edie shares more about her life and science.
Dr. Annaliesa Anderson is Vice President and Chief Scientific Officer of Bacterial Vaccines within Vaccine Research and Development at Pfizer Inc. She earned her PhD in Biological Sciences from the University of Warwick in the UK. Afterwards, Liesa was awarded a Natural Environment Research Council postdoctoral fellowship which she completed at the University of Coventry. She was subsequently awarded a Royal Society postdoctoral fellowship during which she conducted research at the University of Warwick. Next, Liesa worked for about 9 years at Merck Research Laboratories. She then joined the team at Wyeth a few years before it was acquired by Pfizer, and she has been with Pfizer ever since. Liesa is a Member of the Microbiology Society, a Fellow of the American Academy for Microbiology, a Fellow of the Royal Society of Medicine, and she serves on the Microbiology and Infectious Disease Steering Committee at the NY Academy of Sciences. In our interview Annaliesa will share more about her life and science.